Cochrane Abstracts
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tacrolimus Versus Cyclosporin as Primary Immunosuppression for Lung Transplant Recipients." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients.
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients. Accessed December 5, 2024.
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients
Tacrolimus Versus Cyclosporin as Primary Immunosuppression for Lung Transplant Recipients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
ID - 438880
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
